首次出版:最新修訂:March 2009交付方式:特快專遞(2-3天送達)
報告屬性:共149頁下載目錄 版權(quán)聲明
定購電話:0755-82571522、82571566、400-008-1522
24小時服務(wù)熱線:138 0270 8576 定制報告
版本 | 在線版 | 電子版+印刷版 | 在線報告庫(超1000份報告)全庫 |
---|---|---|---|
優(yōu)惠價 | RMB 6800 | RMB 7800 | RMB 9800 |
原價 | RMB 9600 | RMB 9800 | - |
聯(lián)系電話: 400 008 0586; 0755-82571568
微信掃碼:
1.EXECUTIVESUMMARY
·ExecutiveSummary
Introduction
2.MARKETINTRODUCTION
·Overview
ScopeandSegmentation
ResearchMethodology
·DiseaseOverview
Asthma
COPD
TreatmentOptions
·MarketOverview
MarketEngineeringMeasurements
IndustryChallengesandStrategicRecommendations
MarketDrivers
MarketRestraints
3.TOTALMARKETANALYSIS
·CompetitiveAnalysis
CompetitiveStructure
·PatientForecasts
PatientForecasts-Asthma
PatientForecasts-COPD
TotalPatientForecasts
·RevenueForecasts
TotalMarketRevenueForecasts
MarketShareAnalysis
4.BRONCHODILATORSMARKET
·Introduction
Introduction
MarketEngineeringMeasurements
RevenueForecasts
MarketShareAnalysis
·Short-ActingBeta-2AgonistsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·Long-ActingBeta-2AgonistsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·AnticholinergicsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·CombinationBronchodilators
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
5.ANTI-INFLAMMATORYMARKET
·Introduction
Introduction
MarketEngineeringMeasurements
RevenueForecasts
MarketShareAnalysis
·InhaledCorticosteroidsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·Mediator-ReleaseInhibitorMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·Anti-LeukotrieneMarket
Introduction
RevenueForecasts
PipelineAnalysis
·MonoclonalAntibodyMarket
Introduction
RevenueForecasts
PipelineAnalysis
·OtherEmergingAnti-Inflammatories
PipelineAnalysis
6.COMBINATIONTHERAPIESMARKET
·CombinationTherapies
Introduction
MarketEngineeringMeasurements
RevenueForecasts
ProductAnalysis
7.APPENDIX
·DecisionSupportDatabases
MortalityDuetoAsthmaBronchitisandEmphysema
PrevalenceofAsthma
PrevalenceofChronicObstructivePulmonaryDisease
FemalePopulation65andAbove
MalePopulation65andAbove
This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.